
Principal Investigator
GI medical oncologist and physician-scientist at Memorial Sloan Kettering, connecting tumor genomics, ctDNA, immune profiling, and clinical trials to develop precision therapies for pancreatic and biliary tract cancers.
91 publications →
Faculty
124 publications →
Faculty
11 publications →
Faculty
7 publications →
Faculty
Board-certified gastrointestinal medical oncologist at Memorial Sloan Kettering, specializing in pancreatic cancer and developing clinical trials for the next generation of GI cancer treatments.
15 publications →
Senior Research Scholar
Senior Research Scholar studying tumor–immune interactions and mechanisms of immune suppression in cancer.
13 publications →Research Scholar
Leads the lab’s translational work in biliary tract cancer (BTC), extending KRAS/RAS-directed strategies into BTC as part of the GRIT initiative.
6 publications →
Clinical Fellow
7 publications →
Visiting Scientist
First author of the lab’s inaugural biliary tract cancer study, identifying PI3K-pathway activation as a molecular determinant of chemotherapy benefit in advanced BTC (Clinical and Molecular Hepatology, 2026).
2 publications →Member
5 publications →
Member
Student